Back to pipeline

A novel therapy for diastolic heart failure, first in class. Innovative drug for limb ischemia disease and for diseases with loss of muscle mass.

VASA Therapeutics 2

Therapeutic area
Pain Treatment
Location
Poland / USA
Current phase
Advanced Pre-Clinical
Exit
2024
IP
Back to pipeline

Ambulero

Next project
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram